Infection in fracture fixation: can we influence infection rates through implant design?
Musculoskeletal infection is one of the most common complications associated with surgical fixation of bones fractured during trauma. These infections usually involve bacterial colonisation and biofilm formation on the fracture fixation device itself, as well as infection of the surrounding tissues. Antibiotic prophylaxis, wound debridement and postsurgical care can reduce the incidence of, but do not prevent, these infections. Much research and development has been focussed on ways to further reduce the incidence of infection and in the following short review we describe our experiences investigating the contribution of the basic design of fracture fixation devices on the susceptibility to infection. It has been shown in animal studies that device size, shape, mode of action and material and topography play an interrelated role in the susceptibility to infection. Although direct extrapolation from animal studies to the clinical setting is difficult, close consideration of the design factors that can reduce the incidence of infection in animal models is expected to help minimise the incidence of infection associated with any clinically implemented fracture fixation device.
AO Research Institute Davos, AO Foundation, Clavadelerstrasse 8, Davos Platz, 7270, Switzerland.
T Fintan
TF
Moriarty
U
U
Schlegel
S
S
Perren
R Geoff
RG
Richards
D000818:Animals; D019072:Antibiotic Prophylaxis; D001422:Bacterial Adhesion; D001672:Biocompatible Materials; D005593:Fracture Fixation, Internal / Q000009:adverse effects*; D006801:Humans; D007239:Infections / Q000209:etiology* / Q000601:surgery; D009985:Orthopedics; D019736:Prostheses and Implants / Q000009:adverse effects*; D016459:Prosthesis-Related Infections / Q000503:physiopathology / Q000517:prevention & control*
D001672:Biocompatible Materials